Tavo Espinoza
Chief Financial Officer
Replay available
Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Melanie Herman
Executive Director of Investor Relations
Lauren Hay
Vice President of Strategic Planning and Investment Analytics
Annabelle Samimi
Analyst, Stupho
Rich Baxter
Senior Vice President of Investment Operations
Todd Davis
Chief Executive Officer
Matt Hewitt
Analyst, Craig-Hallum Capital Group
Trevor Allred
Analyst, Oppenheimer & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ligand Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.179 simply press start, followed by the number one on your telephone keypad. 00:00:04.179 -- 00:00:07.325 If you would like to withdraw your question, press start one again. 00:00:07.325 -- 00:00:12.435 Thank you. I would now like to turn the call over to Melanie Herman, Executive Director 00:00:12.435 -- 00:00:16.379 of Investor Relations. Please go ahead. 00:00:18.026 -- 00:00:22.762 Good morning, everyone, and welcome to Ligand's first quarter 2025 earnings 00:00:22.762 -- 00:00:26.628 During the call today, we will review the financial results we released earlier today 00:00:26.628 -- 00:00:30.974 and provide commentary on our partnered pipeline and business development activity, followed 00:00:30.974 -- 00:00:35.321 by a question and answer session. Before we get started, I would like to point out that 00:00:35.321 -- 00:00:39.888 we will be discussing non-GAAP results, which excludes certain items such as stock-based 00:00:39.888 -- 00:00:45.056 compensation, amortization of intangible assets, amortization or impairment of financial 00:00:45.056 -- 00:00:50.324 assets, losses from derivative assets, and expenses incurred to incubate the PELPOS business, 00:00:50.324 -- 00:00:52.377 amongst others. 00:00:52.377 -- 00:00:56.942 I encourage you to review the reconciliation of these non-GAAP measures to their most 00:00:56.942 -- 00:01:01.206 directly comparable GAAP measures, which can be found in today's release available on 00:01:01.206 -- 00:01:06.191 our website. We believe these suggested measures provide valuable insight into our core 00:01:06.191 -- 00:01:10.095 operating performance, both historically and going forward. 00:01:10.095 -- 00:01:14.259 Our earnings release and a link to today's webcast can be found in the invest...